Non-Invasive Prenatal Diagnosis for Single Gene Disorders (SGD-NIPD) is a way to check for certain genetic conditions in a baby before birth without using risky procedures. It uses cell-free fetal DNA (cffDNA), which is tiny bits of the baby's DNA that float in the mother's blood. This method can be done as early as 9 weeks into pregnancy and helps avoid the risk of miscarriage. However, the test is challenging because it must pick out the baby's DNA from the mother's DNA. Researchers in France are working to improve this test so it can be used for any genetic disorder.
- Study Length: The test results are ready in about 5-6 working days.
- Eligibility: Pregnant women 18 years or older, with a single baby, and a family history of certain genetic conditions.
- Risks: The test is non-invasive and does not pose the miscarriage risk of traditional tests.
How understandable was the trial content above?
Hard to understand
Easy to understand